Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 May 19;11(5):908.
doi: 10.3390/diagnostics11050908.

BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored

Felice Crocetto  1 , Biagio Barone  1 , Vincenzo Francesco Caputo  1 , Matteo Fontana  2 , Ottavio de Cobelli  2   3 , Matteo Ferro  2
Affiliations
Editorial

BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored

Felice Crocetto et al. Diagnostics (Basel). .

Abstract

Prostate cancer (PCa) is the second most common neoplasm in men and the fifth leading cause of death worldwide [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. McNevin C.S., Baird A.-M., McDermott R., Finn S.P. Diagnostic Strategies for Treatment Selection in Advanced Prostate Cancer. Diagnostics. 2021;11:345. doi: 10.3390/diagnostics11020345. - DOI - PMC - PubMed
    1. Ferro M., Lucarelli G., Crocetto F., Dolce P., Verde A., La Civita E., Zappavigna S., de Cobelli O., Di Lorenzo G., Facchini B.A., et al. First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings. Crit. Rev. Oncol. 2021;157:103198. doi: 10.1016/j.critrevonc.2020.103198. - DOI - PubMed
    1. Buonerba C., Matteo M., Dolce P., Felice C., Verde A., Giuseppe L., Luca S., Sergio F., Angelo V., Alfredo M., et al. Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis. Crit. Rev. Oncol. 2020;151:102992. doi: 10.1016/j.critrevonc.2020.102992. - DOI - PubMed
    1. Angeles A.K., Bauer S., Ratz L., Klauck S.M., Sültmann H. Genome-Based Classification and Therapy of Prostate Cancer. Diagnostics. 2018;8:62. doi: 10.3390/diagnostics8030062. - DOI - PMC - PubMed
    1. Tedaldi G., Tebaldi M., Zampiga V., Cangini I., Pirini F., Ferracci E., Danesi R., Arcangeli V., Ravegnani M., Martinelli G., et al. Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients. Diagnostics. 2020;10:269. doi: 10.3390/diagnostics10050269. - DOI - PMC - PubMed

Publication types